Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Local Phase IV, Gastroesophageal Reflux Disease (GERD) Sleep Study US

ClinicalTrials.gov ID: NCT00660660

Public ClinicalTrials.gov record NCT00660660. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 6:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux Disease (GERD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this research study is to compare the safety and effectiveness (how well the medicine works) of esomeprazole (study drug) to placebo (a capsule that does not contain any medication) taken daily in relieving nighttime heartburn and problems sleeping in patients with gastroesophageal reflux disease (GERD).

Study identification

NCT ID
NCT00660660
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
AstraZeneca
Industry
Enrollment
276 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2008 (Type not available)
Primary completion
Jul 2008 (Actual)
Completion
Jul 2008 (Actual)
Last update posted
Mar 2, 2015

2008

United States locations

U.S. sites
45
U.S. states
21
U.S. cities
45
Facility City State ZIP Site status
Research Site Huntsville Alabama — —
Research Site Tucson Arizona — —
Research Site Little Rock Arkansas — —
Research Site Anaheim California — —
Research Site Burbank California — —
Research Site Castro Valley California — —
Research Site Orange California — —
Research Site San Diego California — —
Research Site Boynton Beach Florida — —
Research Site Coral Springs Florida — —
Research Site DeLand Florida — —
Research Site Hollywood Florida — —
Research Site Jupiter Florida — —
Research Site Pembroke Pines Florida — —
Research Site South Miami Florida — —
Research Site Tampa Florida — —
Research Site Zephyrhills Florida — —
Research Site Stockbridge Georgia — —
Research Site Overland Park Kansas — —
Research Site Lexington Kentucky — —
Research Site Hollywood Maryland — —
Research Site Las Vegas Nevada — —
Research Site Medford New Jersey — —
Research Site Perth Amboy New Jersey — —
Research Site West Orange New Jersey — —
Research Site Albuquerque New Mexico — —
Research Site Binghamton New York — —
Research Site Huntersville North Carolina — —
Research Site Raleigh North Carolina — —
Research Site Winston-Salem North Carolina — —
Research Site Cincinnati Ohio — —
Research Site Dayton Ohio — —
Research Site Kettering Ohio — —
Research Site Oklahoma City Oklahoma — —
Research Site Chattanooga Tennessee — —
Research Site Johnson City Tennessee — —
Research Site Amarillo Texas — —
Research Site Fort Worth Dallas Texas — —
Research Site Houston Texas — —
Research Site Ogden Utah — —
Research Site Burke Virginia — —
Research Site Christiansburg Virginia — —
Research Site Fredericksburg Virginia — —
Research Site Newport News Virginia — —
Research Site Bellevue Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00660660, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 2, 2015 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00660660 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →